In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […]
Biosimilar Patent Dance: Leveraging PTAB Challenges for Strategic Advantage Read Post »
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research
Viagra’s Resilience in the Face of Generic Competition: A Pharmaceutical Market Analysis Read Post »
The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to
The impact of biosimilars on biologic drug distribution models Read Post »
In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent
Unified Patent Court Reshapes European Patent Landscape Read Post »
To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or
How to find low-competition generic drug opportunities Read Post »
The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI’s ability to analyze
Patenting Drugs Developed with Artificial Intelligence: Navigating the Legal Landscape Read Post »
China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It
New patent expiration for Abbvie drug ORILISSA Read Post »
The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most
The Power of Patience: Delaying Patents to Enhance Pharma Market Exclusivity Read Post »
Get fresh news and insights, drug patent expirations & more…
